Cargando…
免疫检查点抑制剂相关内分泌不良反应的临床诊治建议
As a new type of anti-cancer drugs, immune checkpoint inhibitors (ICIs) have shown remarkable therapeutic effects in many malignant tumors. By virtue of their targets and mechanisms of action, ICIs can cause autoimmune and inflammatory effects, termed immune-related adverse events (irAEs). Unlike tr...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817430/ https://www.ncbi.nlm.nih.gov/pubmed/31650948 http://dx.doi.org/10.3779/j.issn.1009-3419.2019.10.08 |